J&J CEO calls drug recalls a “disappointment”
NEW YORK (Reuters) – Johnson & Johnson Chief Executive Bill Weldon told consumers in an open letter published on Friday on the drugmaker’s blog that the recent recalls of some of its medicines were “a disappointment to me” and to the company and its employees.
Read more on Reuters
